Total Payments
$6,038
2024 Payments
$634.26
Companies
27
Transactions
280
Medicare Patients
9,485
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$6,038 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,038 | 280 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $969.76 | 37 | $0 (2024) |
| Boston Scientific Corporation | $741.38 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $505.03 | 33 | $0 (2024) |
| Amgen Inc. | $400.93 | 19 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $393.69 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $368.86 | 23 | $0 (2024) |
| PFIZER INC. | $351.90 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $339.89 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $295.49 | 15 | $0 (2023) |
| Novo Nordisk Inc | $284.67 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $634.26 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.35) |
| 2023 | $701.58 | 25 | Boston Scientific Corporation ($176.57) |
| 2022 | $687.55 | 41 | Novartis Pharmaceuticals Corporation ($166.28) |
| 2021 | $663.91 | 30 | BOSTON SCIENTIFIC CORPORATION ($220.96) |
| 2020 | $309.31 | 17 | PFIZER INC. ($108.12) |
| 2019 | $789.80 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($149.84) |
| 2018 | $1,096 | 53 | Amgen Inc. ($214.55) |
| 2017 | $1,155 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($170.85) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Cardiovascular | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Cardiovascular | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: Cardiovascular | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $140.64 | General |
| Category: LUX-Dx_CRM | ||||||
| 01/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: DIABETES | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,557 | 9,094 | $8.7M | $473,481 |
| 2022 | 11 | 2,733 | 9,935 | $8.7M | $536,772 |
| 2021 | 12 | 2,201 | 7,688 | $7.2M | $454,733 |
| 2020 | 9 | 1,994 | 5,987 | $5.2M | $394,248 |
Total Patients
9,485
Total Services
32,704
Medicare Billing
$1.9M
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 702 | 3,720 | $5.2M | $274,015 | 5.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 516 | 582 | $1.5M | $70,957 | 4.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 206 | 224 | $560,000 | $36,138 | 6.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 194 | 297 | $423,650 | $32,893 | 7.8% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 637 | 3,924 | $41,236 | $24,407 | 59.2% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 82 | 85 | $630,000 | $14,160 | 2.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 147 | 155 | $232,500 | $9,455 | 4.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 61 | $21,350 | $7,266 | 34.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 19 | $52,250 | $3,811 | 7.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 27 | $13,500 | $377.46 | 2.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 683 | 3,346 | $4.0M | $221,452 | 5.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 250 | 1,168 | $1.4M | $110,828 | 7.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 548 | 622 | $1.6M | $78,990 | 5.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 245 | 281 | $702,500 | $51,867 | 7.4% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 638 | 4,079 | $72,640 | $25,983 | 35.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 110 | 117 | $585,000 | $19,925 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 96 | $33,600 | $11,198 | 33.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 147 | 154 | $231,000 | $9,673 | 4.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 30 | $82,500 | $6,184 | 7.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 26 | $13,000 | $364.70 | 2.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2022 | 16 | 16 | $8,000 | $307.23 | 3.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 509 | 2,848 | $3.4M | $192,468 | 5.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 192 | 764 | $916,800 | $74,018 | 8.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 324 | 364 | $910,000 | $68,596 | 7.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 291 | 330 | $825,000 | $42,544 | 5.2% |
About Mark Kahn
Mark Kahn is a Internal Medicine healthcare provider based in Syosset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1134443112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Kahn has received a total of $6,038 in payments from pharmaceutical and medical device companies, with $634.26 received in 2024. These payments were reported across 280 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,038).
As a Medicare-enrolled provider, Kahn has provided services to 9,485 Medicare beneficiaries, totaling 32,704 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Syosset, NY
- Active Since 03/20/2010
- Last Updated 01/22/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134443112
Products in Payments
- JARDIANCE (Drug) $967.64
- ELIQUIS (Drug) $651.78
- WATCHMAN (Device) $401.87
- FARXIGA (Drug) $393.69
- ENTRESTO (Drug) $362.43
- VERQUVO (Drug) $321.95
- Repatha (Biological) $200.67
- TOUJEO (Drug) $181.20
- WATCHMAN Access System (Device) $167.60
- Pacemakers (Device) $162.45
- XARELTO (Drug) $157.83
- Corlanor (Drug) $147.13
- LUX-Dx Insertable Cardiac Monitor (Device) $140.64
- Korlym (Drug) $139.24
- INVOKANA (Drug) $137.66
- LEQVIO (Drug) $123.82
- Victoza (Drug) $118.43
- TRADJENTA (Drug) $117.90
- Belviq (Drug) $114.74
- HUMULIN (Drug) $106.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Syosset
Dr. Fredric Mintz, M.d, M.D
Internal Medicine — Payments: $9,435
Internal Medicine $9,435
Stephen Bernstein, Md, MD
Internal Medicine — Payments: $7,861
Internal Medicine $7,861
Dr. Gary Moskowitz, D.o, D.O
Internal Medicine — Payments: $5,272
Internal Medicine $5,272
Dr. Richard Iammatteo, M.d, M.D
Internal Medicine — Payments: $1,292
Internal Medicine $1,292
Venugopal Palla, Md, MD
Internal Medicine — Payments: $1,091
Internal Medicine $1,091
Dr. Richard Federbush, M.d, M.D
Internal Medicine — Payments: $1,064
Internal Medicine $1,064